|Bid||0.50 x 0|
|Ask||0.56 x 0|
|Day's Range||0.50 - 0.52|
|52 Week Range||0.50 - 7.43|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
SAN DIEGO, Dec. 06, 2017-- TearLab Corporation, today announced the pricing of a registered direct offering of 6,818,182 units at a purchase price of $0.44 each, raising gross proceeds of $3.0 million, ...
SAN DIEGO, Nov. 30, 2017-- TearLab Corporation, today announced that it is launching a registered direct offering to raise gross proceeds of approximately $3.0 million, prior to any placement agent commissions ...
SAN DIEGO, Nov. 13, 2017-- TearLab Corporation today reported its consolidated financial results for the third quarter and nine months ended September 30, 2017. All dollar amounts are expressed in U.S. ...
SAN DIEGO, Nov. 09, 2017-- TearLab Corporation, today announced that shares of its common stock will begin trading on the OTCQB Market, which is operated by OTC Markets Group Inc., effective with the open ...
SAN DIEGO, Nov. 01, 2017-- TearLab Corporation will announce its third quarter 2017 financial results after market close on Monday, November 13, 2017.. TearLab’ s Chief Executive Officer, Seph Jensen and ...
SAN DIEGO, Oct. 17, 2017-- TearLab Corporation today provided an update on the regulatory strategy for its TearLab Discovery™ System, the Company’ s next-generation in-vitro diagnostics testing platform. ...
Zacks.com featured highlights include MINDBODY, TearLab, Sunesis Pharmaceuticals, Children's Place, Franklin Electric